- For U.S. Healthcare Professionals only
- Patient Site
- Indications
Indication
AUGTYROTM (repotrectinib) is indicated for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC).
- U.S. Full Prescribing Information
- Patient Information
- Patient Site
REQUEST A REP
ERROR 404
THE PAGE YOU ARE TRYING TO ACCESS IS NOT AVAILABLE.
You may have accessed this page via an outdated link, or typed the URL incorrectly.
Visit the home page to learn more.
BACK TO HOME